نتایج جستجو برای: apoptosis memantine

تعداد نتایج: 157062  

2011
LAURIAN VLASE MARCELA ACHIM DANA MUNTEAN ADRIAN GAL CORNEL CĂTOI CONSTANTIN BODOLEA SORIN E. LEUCUŢA

A pharmacokinetic study of intravenously and orally administered memantine was run on 12 pigs. The blood samples were collected up to 12 hours after drug administration. The memantine plasma levels were determined using a validated method of liquid chromatography coupled with mass spectrometry detection. Six pharmacokinetic models were screened and the best one describing the absorption and dis...

Journal: :Neuropsychiatric Disease and Treatment 2007
Rajesh R Tampi Christopher H van Dyck

Alzheimer's disease (AD) is the most common cause of dementia, accounting for 25 million cases worldwide. Until recently, the pharmacotherapy of AD was limited to the use of cholinesterase inhibitors (ChEIs) that are approved only for the mild to moderate stages of the illness. Memantine, an NMDA receptor antagonist has been found to be effective, both as monotherapy and in combination with don...

Journal: :Pharmacological reports : PR 2014
Renny Abraham Ramakrishna Nirogi Anil Shinde

BACKGROUND It is a well-known fact that 5HT6 ligands increase glutamate levels. In the current study we investigated whether a 5HT6 antagonist, SB399885 would show antidepressant like property at a dose which would significantly increase the glutamate levels. Further we studied if the combination of a 5HT6 antagonist and N-methyl-D-aspartate (NMDA) antagonist, memantine would restore the antide...

2012
Susanne Hartz Denis Getsios Sunning Tao Steve Blume Grant Maclaine

BACKGROUND Previous cost-effectiveness studies of cholinesterase inhibitors have modeled Alzheimer's disease (AD) progression and treatment effects through single or global severity measures, or progression to "Full Time Care". This analysis evaluates the cost-effectiveness of donepezil versus memantine or no treatment in Germany by considering correlated changes in cognition, behavior and func...

Journal: :Investigative ophthalmology & visual science 2004
William A Hare Elizabeth WoldeMussie Ronald K Lai Hau Ton Guadalupe Ruiz Teresa Chun Larry Wheeler

PURPOSE To determine, using electrophysiological measures of visual system function, whether oral daily dosing of memantine is both safe and effective to reduce the injury associated with experimental glaucoma in primates. METHODS Argon laser treatment of the anterior chamber angle was used to induce chronic ocular hypertension (COHT) in the right eye of 18 macaque monkeys. Nine animals were ...

2012
Laura E. Pope Kerri A. Schoedel Cynthia Bartlett Edward M. Sellers

BACKGROUND AND OBJECTIVE Dextromethorphan/quinidine (DMQ) is the first agent indicated for the treatment of pseudobulbar affect. Dextromethorphan, the active ingredient, is a low-affinity, uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist. This study evaluated the potential for a drug-drug interaction (DDI) of DMQ with memantine, which is also an NMDA receptor antagonist. METHODS ...

Journal: :JAMA 2014
Maurice W Dysken Mary Sano Sanjay Asthana Julia E Vertrees Muralidhar Pallaki Maria Llorente Susan Love Gerard D Schellenberg J Riley McCarten Julie Malphurs Susana Prieto Peijun Chen David J Loreck George Trapp Rajbir S Bakshi Jacobo E Mintzer Judith L Heidebrink Ana Vidal-Cardona Lillian M Arroyo Angel R Cruz Sally Zachariah Neil W Kowall Mohit P Chopra Suzanne Craft Stephen Thielke Carolyn L Turvey Catherine Woodman Kimberly A Monnell Kimberly Gordon Julie Tomaska Yoav Segal Peter N Peduzzi Peter D Guarino

IMPORTANCE Although vitamin E and memantine have been shown to have beneficial effects in moderately severe Alzheimer disease (AD), evidence is limited in mild to moderate AD. OBJECTIVE To determine if vitamin E (alpha tocopherol), memantine, or both slow progression of mild to moderate AD in patients taking an acetylcholinesterase inhibitor. DESIGN, SETTING, AND PARTICIPANTS Double-blind, ...

Journal: :The Clinical journal of pain 2007
Nektarios Sinis Niels Birbaumer Sylvia Gustin Anja Schwarz Sabine Bredanger Stephan Thomas Becker Klaus Unertl Hans-Eberhard Schaller Max Haerle

OBJECTIVES Recent studies have confirmed the contribution of the central nervous system (CNS) to the pathogenesis of Complex Regional Pain Syndrome (CRPS), because animal models of neuropathic pain syndromes demonstrate an overexpression of N-methyl-D-aspartate-receptors in the CNS. The aim of this work was to study the influence of a central acting drug-the N-methyl-D-aspartate receptor antago...

Journal: :Journal of Alzheimer's disease : JAD 2011
Jörg B Schulz Michael Rainer Hans-Hermann Klünemann Alexander Kurz Stefanie Wolf Kati Sternberg Frank Tennigkeit

The present study evaluated the effects of once-daily memantine (20 mg) treatment on cognition and communication in patients with moderate to severe Alzheimer's disease (AD). In a multicenter, single-arm open-label study, outpatients diagnosed with AD (MMSE < 20; n = 97) were titrated from 5 mg to 20 mg once-daily memantine over 4 weeks. Once-daily memantine treatment (20 mg) was then continued...

Journal: :The Journal of pharmacology and experimental therapeutics 2003
Gino Villetti Marco Bergamaschi Franco Bassani Pier Tonino Bolzoni Marisa Maiorino Claudio Pietra Ivano Rondelli Philippe Chamiot-Clerc Michele Simonato Mario Barbieri

N-(2-Indanyl)-glycinamide hydrochloride (CHF3381) is a novel low-affinity, noncompetitive N-methyl-d-aspartate receptor antagonist. The current study compared the antinociceptive effects of CHF3381 with those of gabapentin and memantine in in vitro and in vivo models of pain. In isolated rat spinal cord, CHF3381 and memantine, but not gabapentin, produced similar inhibition of the wind-up pheno...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید